The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Collective analysis of efficacy and safety of patients with advanced hepatocellular carcinoma (HCC) enrolled into early-phase clinical trials.
Vinu Madhusudanannair
No relevant relationships to disclose
Brad H. Pollock
No relevant relationships to disclose
Norma Ketchum
No relevant relationships to disclose
Steven Weitman
No relevant relationships to disclose
John Sarantopoulos
No relevant relationships to disclose
Devalingam Mahalingam
No relevant relationships to disclose